Antagonism of Tumoral Prolactin Receptor Promotes Autophagy-Related Cell Death

Cell Reports

Volumn 7, Issue 2, 2014, Pages 488-500

  Wen, Yunfei ^a   Zand, Behrouz ^a   Ozpolat, Bulent ^a   Szczepanski, MiroslawJ ^e   Lu, Chunhua ^a   Yuca, Erkan ^a   Carroll, AmyR ^a   Alpay, Neslihan ^a   Bartholomeusz, Chandra ^a   Tekedereli, Ibrahim ^a   Kang, Yu ^a   Rupaimoole, Rajesha ^a   Pecot, ChadV ^a   Dalton, HeatherJ ^a   Hernandez, Anadulce ^a   Lokshin, Anna ^b   Lutgendorf, SusanK ^c   Liu, Jinsong ^a   Hittelman, WalterN ^a   Chen, WenY ^d   Lopez Berestein, Gabriel ^a   Szajnik, Marta ^f   Ueno, Naoto T ^g   Coleman, Robert L ^a   Sood, Anil K ^a   more..

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d CLEMSON UNIVERSITY   (United States)

^e MEDICAL UNIVERSITY OF WARSAW   (Poland)

^f POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^g University of Houston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; G 129R; PACLITAXEL; PHOSPHOPROTEIN; PROLACTIN RECEPTOR; PROTEIN KINASE C ZETA; PROTEIN PEA 15; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PEA15 PROTEIN, HUMAN; PROLACTIN; PROLACTIN, ARG(129)-; PROTEIN KINASE C; SIGNAL PEPTIDE; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOLYSOSOME; AUTOPHAGY; CANCER CELL; CANCER SURVIVAL; CELL SURVIVAL; CELL VACUOLE; CELL VIABILITY; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OVARY CANCER; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TREATMENT DURATION; TUMOR GROWTH; ANTAGONISTS AND INHIBITORS; CARCINOMA; CELL DEATH; DRUG EFFECTS; FEMALE; METABOLISM; MULTICELLULAR SPHEROID; OVARIAN NEOPLASMS; TUMOR CELL LINE;

APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BIOMARKERS, TUMOR; CARCINOMA; CELL DEATH; CELL LINE, TUMOR; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; OVARIAN NEOPLASMS; PHOSPHOPROTEINS; PROLACTIN; PROTEIN KINASE C; RECEPTORS, PROLACTIN; SPHEROIDS, CELLULAR;

EID: 84899626487     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.03.009     Document Type: Article

References (38)

1. Akar U., Chaves-Reyez A., Barria M., Tari A., Sanguino A., Kondo Y., Kondo S., Arun B., Lopez-Berestein G., Ozpolat B. Silencing of Bcl-2 expression by small interfering RNA induces autophagic cell death in MCF-7 breast cancer cells. Autophagy 2008, 4:669-679.
2. Amaravadi R.K., Lippincott-Schwartz J., Yin X.M., Weiss W.A., Takebe N., Timmer W., DiPaola R.S., Lotze M.T., White E. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 2011, 17:654-666.
3. Asai-Sato M., Nagashima Y., Miyagi E., Sato K., Ohta I., Vonderhaar B.K., Hirahara F. Prolactin inhibits apoptosis of ovarian carcinoma cellsinduced by serum starvation or cisplatin treatment. Int. J. Cancer 2005, 115:539-544.
4. Bartholomeusz C., Rosen D., Wei C., Kazansky A., Yamasaki F., Takahashi T., Itamochi H., Kondo S., Liu J., Ueno N.T. PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res. 2008, 68:9302-9310.
5. Bartholomeusz C., Gonzalez-Angulo A.M., Kazansky A., Krishnamurthy S., Liu P., Yuan L.X., Yamasaki F., Liu S., Hayashi N., Zhang D., et al. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase. Clin. Cancer Res. 2010, 16:1802-1811.
6. Bursch W., Ellinger A., Kienzl H., Török L., Pandey S., Sikorska M., Walker R., Hermann R.S. Active cell death induced by the anti-estrogens tamoxifen and ICI 164 384 in human mammary carcinoma cells (MCF-7) in culture: the role of autophagy. Carcinogenesis 1996, 17:1595-1607.
7. Castino R., Bellio N., Follo C., Murphy D., Isidoro C. Inhibition of PI3k class III-dependent autophagy prevents apoptosis and necrosis by oxidative stress in dopaminergic neuroblastoma cells. Toxicol. Sci. 2010, 117:152-162.
8. Crowe P.D., Buckley A.R., Zorn N.E., Rui H. Prolactin activates protein kinase C and stimulates growth-related gene expression in rat liver. Mol. Cell. Endocrinol. 1991, 79:29-35.
9. Cruz-Soto M.E., Scheiber M.D., Gregerson K.A., Boivin G.P., Horseman N.D. Pituitary tumorigenesis in prolactin gene-disrupted mice. Endocrinology 2002, 143:4429-4436.
10. Dalby K.N., Tekedereli I., Lopez-Berestein G., Ozpolat B. Targeting the prodeath and prosurvival functions of autophagy as novel therapeutic strategies in cancer. Autophagy 2010, 6:322-329.
11. Debnath J., Brugge J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 2005, 5:675-688.
12. Demarchi F., Bertoli C., Copetti T., Eskelinen E.L., Schneider C. Calpain as a novel regulator of autophagosome formation. Autophagy 2007, 3:235-237.
13. Dikic I., Johansen T., Kirkin V. Selective autophagy in cancer development and therapy. Cancer Res. 2010, 70:3431-3434.
14. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 1998, 95:2509-2514.
15. Kimura S., Noda T., Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007, 3:452-460.
16. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., Agholme L., Agnello M., Agostinis P., Aguirre-Ghiso J.A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
17. Kubes M., Cordier J., Glowinski J., Girault J.A., Chneiweiss H. Endothelin induces a calcium-dependent phosphorylation of PEA-15 in intact astrocytes: identification of Ser104 and Ser116 phosphorylated, respectively, by protein kinase C and calcium/calmodulin kinase II invitro. J.Neurochem. 1998, 71:1307-1314.
18. Levina V.V., Nolen B., Su Y., Godwin A.K., Fishman D., Liu J., Mor G., Maxwell L.G., Herberman R.B., Szczepanski M.J., et al. Biological significance of prolactin in gynecologic cancers. Cancer Res. 2009, 69:5226-5233.
19. Levine B., Sinha S., Kroemer G. Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy 2008, 4:600-606.
20. Li L., Lu Y. Optimizing a 3D Culture System to Study the Interaction between Epithelial Breast Cancer and Its Surrounding Fibroblasts. J.Cancer 2011, 2:458-466.
21. Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H., Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999, 402:672-676.
22. Llovera M., Pichard C., Bernichtein S., Jeay S., Touraine P., Kelly P.A., Goffin V. Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene 2000, 19:4695-4705.
23. Mathew R., Karantza-Wadsworth V., White E. Role of autophagy in cancer. Nat. Rev. Cancer 2007, 7:961-967.
24. Meng N., Wu L., Gao J., Zhao J., Su L., Su H., Zhang S., Miao J. Lipopolysaccharide induces autophagy through BIRC2 in human umbilical vein endothelial cells. J.Cell. Physiol. 2010, 225:174-179.
25. Mor G., Visintin I., Lai Y., Zhao H., Schwartz P., Rutherford T., Yue L., Bray-Ward P., Ward D.C. Serum protein markers for early detection of ovarian cancer. Proc. Natl. Acad. Sci. USA 2005, 102:7677-7682.
26. Quinsay M.N., Thomas R.L., Lee Y., Gustafsson A.B. Bnip3-mediated mitochondrial autophagy is independent of the mitochondrial permeability transition pore. Autophagy 2010, 6:855-862.
27. Rubinsztein D.C., Gestwicki J.E., Murphy L.O., Klionsky D.J. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 2007, 6:304-312.
28. Rui H., Kirken R.A., Farrar W.L. Activation of receptor-associated tyrosine kinase JAK2 by prolactin. J.Biol. Chem. 1994, 269:5364-5368.
29. Shimizu S., Kanaseki T., Mizushima N., Mizuta T., Arakawa-Kobayashi S., Thompson C.B., Tsujimoto Y. Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat. Cell Biol. 2004, 6:1221-1228.
30. Sulzmaier F., Opoku-Ansah J., Ramos J.W. Phosphorylation is the switch that turns PEA-15 from tumor suppressor to tumor promoter. Small GTPases 2012, 3:173-177.
31. Tan D., Chen K.E., Khoo T., Walker A.M. Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists. Cancer Lett. 2011, 310:101-108.
32. Trencia A., Perfetti A., Cassese A., Vigliotta G., Miele C., Oriente F., Santopietro S., Giacco F., Condorelli G., Formisano P., Beguinot F. Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action. Mol. Cell. Biol. 2003, 23:4511-4521.
33. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int. J. Pharm. 2000, 203:1-60.
34. White E., Karp C., Strohecker A.M., Guo Y., Mathew R. Role of autophagy in suppression of inflammation and cancer. Curr. Opin. Cell Biol. 2010, 22:212-217.
35. Xie J., LeBaron M.J., Nevalainen M.T., Rui H. Role of tyrosine kinase Jak2 in prolactin-induced differentiation and growth of mammary epithelial cells. J.Biol. Chem. 2002, 277:14020-14030.
36. Xu J., Zhang Y., Berry P.A., Jiang J., Lobie P.E., Langenheim J.F., Chen W.Y., Frank S.J. Growth hormone signaling in human T47D breast cancer cells: potential role for a growth hormone receptor-prolactin receptor complex. Mol. Endocrinol. 2011, 25:597-610.
37. Yamamoto A., Tagawa Y., Yoshimori T., Moriyama Y., Masaki R., Tashiro Y. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 1998, 23:33-42.
38. Yu L., Alva A., Su H., Dutt P., Freundt E., Welsh S., Baehrecke E.H., Lenardo M.J. Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8. Science 2004, 304:1500-1502.